Clinical trial
Electrical Cardioversion of Recent Onset Atrial Fibrillation - a Study of Silent Thromboembolic Events, Reverse Atrial Electrical and Functional Remodeling Including Inflammatory, Neurohormonal and Thromboembolic Biomarkers
NCT02955004 is registered in ClinicalTrials.gov with Uppsala University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Electrical Cardioversion of Recent Onset Atrial Fibrillation - a Study of Silent Thromboembolic Events, Reverse Atrial Electrical and Functional Remodeling Including Inflammatory, Neurohormonal and Thromboembolic Biomarkers
- Lead sponsor
- Uppsala University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- December 31, 2017
- Enrollment
- 43 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.